COLOPLAST-B (CBHD.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:CBHD • DK0060448595

66.78 EUR
-5.5 (-7.61%)
Last: Feb 6, 2026, 07:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to CBHD. CBHD was compared to 63 industry peers in the Health Care Equipment & Supplies industry. CBHD scores excellent on profitability, but there are some minor concerns on its financial health. CBHD has a decent growth rate and is not valued too expensively. Finally CBHD also has an excellent dividend rating. These ratings could make CBHD a good candidate for dividend investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year CBHD was profitable.
  • CBHD had a positive operating cash flow in the past year.
  • In the past 5 years CBHD has always been profitable.
  • CBHD had a positive operating cash flow in each of the past 5 years.
CBHD.DE Yearly Net Income VS EBIT VS OCF VS FCFCBHD.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 7.52%, CBHD belongs to the top of the industry, outperforming 80.95% of the companies in the same industry.
  • CBHD's Return On Equity of 22.55% is amongst the best of the industry. CBHD outperforms 90.48% of its industry peers.
  • With an excellent Return On Invested Capital value of 12.65%, CBHD belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
  • CBHD had an Average Return On Invested Capital over the past 3 years of 13.59%. This is above the industry average of 9.98%.
Industry RankSector Rank
ROA 7.52%
ROE 22.55%
ROIC 12.65%
ROA(3y)9.32%
ROA(5y)14.2%
ROE(3y)26.12%
ROE(5y)38.84%
ROIC(3y)13.59%
ROIC(5y)18.83%
CBHD.DE Yearly ROA, ROE, ROICCBHD.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

1.3 Margins

  • Looking at the Profit Margin, with a value of 13.04%, CBHD is in the better half of the industry, outperforming 76.19% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CBHD has declined.
  • With an excellent Operating Margin value of 27.52%, CBHD belongs to the best of the industry, outperforming 93.65% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CBHD has declined.
  • CBHD has a better Gross Margin (67.97%) than 76.19% of its industry peers.
  • In the last couple of years the Gross Margin of CBHD has remained more or less at the same level.
Industry RankSector Rank
OM 27.52%
PM (TTM) 13.04%
GM 67.97%
OM growth 3Y-3.48%
OM growth 5Y-2.71%
PM growth 3Y-14.46%
PM growth 5Y-10.44%
GM growth 3Y-0.39%
GM growth 5Y-0.01%
CBHD.DE Yearly Profit, Operating, Gross MarginsCBHD.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CBHD is creating value.
  • CBHD has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, CBHD has more shares outstanding
  • The debt/assets ratio for CBHD has been reduced compared to a year ago.
CBHD.DE Yearly Shares OutstandingCBHD.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
CBHD.DE Yearly Total Debt VS Total AssetsCBHD.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.2 Solvency

  • An Altman-Z score of 3.66 indicates that CBHD is not in any danger for bankruptcy at the moment.
  • With a decent Altman-Z score value of 3.66, CBHD is doing good in the industry, outperforming 68.25% of the companies in the same industry.
  • The Debt to FCF ratio of CBHD is 4.34, which is a neutral value as it means it would take CBHD, 4.34 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of CBHD (4.34) is comparable to the rest of the industry.
  • CBHD has a Debt/Equity ratio of 1.24. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of CBHD (1.24) is worse than 80.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF 4.34
Altman-Z 3.66
ROIC/WACC2.17
WACC5.84%
CBHD.DE Yearly LT Debt VS Equity VS FCFCBHD.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.3 Liquidity

  • A Current Ratio of 1.61 indicates that CBHD should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.61, CBHD perfoms like the industry average, outperforming 49.21% of the companies in the same industry.
  • A Quick Ratio of 1.00 indicates that CBHD should not have too much problems paying its short term obligations.
  • CBHD has a Quick ratio (1.00) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.61
Quick Ratio 1
CBHD.DE Yearly Current Assets VS Current LiabilitesCBHD.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

4

3. Growth

3.1 Past

  • The earnings per share for CBHD have decreased strongly by -38.51% in the last year.
  • The Earnings Per Share has been decreasing by -2.02% on average over the past years.
  • CBHD shows a small growth in Revenue. In the last year, the Revenue has grown by 3.12%.
  • CBHD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.49% yearly.
EPS 1Y (TTM)-38.51%
EPS 3Y-7.04%
EPS 5Y-2.02%
EPS Q2Q%-87.05%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y7.27%
Revenue growth 5Y8.49%
Sales Q2Q%-1.05%

3.2 Future

  • CBHD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.23% yearly.
  • The Revenue is expected to grow by 6.95% on average over the next years.
EPS Next Y46.9%
EPS Next 2Y27.22%
EPS Next 3Y21.12%
EPS Next 5Y16.23%
Revenue Next Year4.89%
Revenue Next 2Y6.18%
Revenue Next 3Y6.54%
Revenue Next 5Y6.95%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CBHD.DE Yearly Revenue VS EstimatesCBHD.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B
CBHD.DE Yearly EPS VS EstimatesCBHD.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10 20 30

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 36.90, the valuation of CBHD can be described as expensive.
  • Compared to the rest of the industry, the Price/Earnings ratio of CBHD is on the same level as its industry peers.
  • CBHD is valuated rather expensively when we compare the Price/Earnings ratio to 27.93, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 17.35 indicates a rather expensive valuation of CBHD.
  • CBHD's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CBHD is cheaper than 68.25% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of CBHD to the average of the S&P500 Index (27.77), we can say CBHD is valued slightly cheaper.
Industry RankSector Rank
PE 36.9
Fwd PE 17.35
CBHD.DE Price Earnings VS Forward Price EarningsCBHD.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CBHD indicates a somewhat cheap valuation: CBHD is cheaper than 63.49% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, CBHD is valued cheaper than 80.95% of the companies in the same industry.
Industry RankSector Rank
P/FCF 20.09
EV/EBITDA 13.87
CBHD.DE Per share dataCBHD.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of CBHD may justify a higher PE ratio.
  • CBHD's earnings are expected to grow with 21.12% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.79
PEG (5Y)N/A
EPS Next 2Y27.22%
EPS Next 3Y21.12%

7

5. Dividend

5.1 Amount

  • CBHD has a Yearly Dividend Yield of 4.28%, which is a nice return.
  • Compared to an average industry Dividend Yield of 0.97, CBHD pays a better dividend. On top of this CBHD pays more dividend than 98.41% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.81, CBHD pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.28%

5.2 History

  • The dividend of CBHD has a limited annual growth rate of 5.30%.
Dividend Growth(5Y)5.3%
Div Incr Years0
Div Non Decr Years0
CBHD.DE Yearly Dividends per shareCBHD.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

5.3 Sustainability

  • 136.36% of the earnings are spent on dividend by CBHD. This is not a sustainable payout ratio.
  • The dividend of CBHD is growing, but earnings are growing more, so the dividend growth is sustainable.
DP136.36%
EPS Next 2Y27.22%
EPS Next 3Y21.12%
CBHD.DE Yearly Income VS Free CF VS DividendCBHD.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B
CBHD.DE Dividend Payout.CBHD.DE Dividend Payout, showing the Payout Ratio.CBHD.DE Dividend Payout.PayoutRetained Earnings

COLOPLAST-B

FRA:CBHD (2/6/2026, 7:00:00 PM)

66.78

-5.5 (-7.61%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-06
Earnings (Next)05-12
Inst Owners28.86%
Inst Owner ChangeN/A
Ins Owners29.79%
Ins Owner ChangeN/A
Market Cap14.04B
Revenue(TTM)27.87B
Net Income(TTM)3.64B
Analysts70.4
Price Target88.27 (32.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.28%
Yearly Dividend2.95
Dividend Growth(5Y)5.3%
DP136.36%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-25%
Min EPS beat(2)-26.06%
Max EPS beat(2)-23.94%
EPS beat(4)0
Avg EPS beat(4)-20.18%
Min EPS beat(4)-26.06%
Max EPS beat(4)-15.32%
EPS beat(8)0
Avg EPS beat(8)-12.22%
EPS beat(12)0
Avg EPS beat(12)-10.75%
EPS beat(16)1
Avg EPS beat(16)-9.6%
Revenue beat(2)0
Avg Revenue beat(2)-2.46%
Min Revenue beat(2)-2.79%
Max Revenue beat(2)-2.12%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-2.79%
Max Revenue beat(4)-0.41%
Revenue beat(8)1
Avg Revenue beat(8)-1.37%
Revenue beat(12)1
Avg Revenue beat(12)-1.51%
Revenue beat(16)4
Avg Revenue beat(16)-0.95%
PT rev (1m)-3.97%
PT rev (3m)-4.84%
EPS NQ rev (1m)-4.55%
EPS NQ rev (3m)-1.6%
EPS NY rev (1m)0.08%
EPS NY rev (3m)0.83%
Revenue NQ rev (1m)-0.33%
Revenue NQ rev (3m)5.75%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.69%
Valuation
Industry RankSector Rank
PE 36.9
Fwd PE 17.35
P/S 3.76
P/FCF 20.09
P/OCF 15.77
P/B 6.5
P/tB N/A
EV/EBITDA 13.87
EPS(TTM)1.81
EY2.71%
EPS(NY)3.85
Fwd EY5.76%
FCF(TTM)3.32
FCFY4.98%
OCF(TTM)4.23
OCFY6.34%
SpS17.76
BVpS10.27
TBVpS-8.72
PEG (NY)0.79
PEG (5Y)N/A
Graham Number20.45
Profitability
Industry RankSector Rank
ROA 7.52%
ROE 22.55%
ROCE 18.32%
ROIC 12.65%
ROICexc 12.94%
ROICexgc 47.68%
OM 27.52%
PM (TTM) 13.04%
GM 67.97%
FCFM 18.72%
ROA(3y)9.32%
ROA(5y)14.2%
ROE(3y)26.12%
ROE(5y)38.84%
ROIC(3y)13.59%
ROIC(5y)18.83%
ROICexc(3y)13.93%
ROICexc(5y)19.56%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.68%
ROCE(5y)29.74%
ROICexgc growth 3Y-12.46%
ROICexgc growth 5Y-4.64%
ROICexc growth 3Y-7.18%
ROICexc growth 5Y-21.95%
OM growth 3Y-3.48%
OM growth 5Y-2.71%
PM growth 3Y-14.46%
PM growth 5Y-10.44%
GM growth 3Y-0.39%
GM growth 5Y-0.01%
F-Score6
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF 4.34
Debt/EBITDA 2.2
Cap/Depr 98.21%
Cap/Sales 5.12%
Interest Coverage 9.3
Cash Conversion 72.84%
Profit Quality 143.51%
Current Ratio 1.61
Quick Ratio 1
Altman-Z 3.66
F-Score6
WACC5.84%
ROIC/WACC2.17
Cap/Depr(3y)106.21%
Cap/Depr(5y)137.78%
Cap/Sales(3y)5.05%
Cap/Sales(5y)6.06%
Profit Quality(3y)77.98%
Profit Quality(5y)77.41%
High Growth Momentum
Growth
EPS 1Y (TTM)-38.51%
EPS 3Y-7.04%
EPS 5Y-2.02%
EPS Q2Q%-87.05%
EPS Next Y46.9%
EPS Next 2Y27.22%
EPS Next 3Y21.12%
EPS Next 5Y16.23%
Revenue 1Y (TTM)3.12%
Revenue growth 3Y7.27%
Revenue growth 5Y8.49%
Sales Q2Q%-1.05%
Revenue Next Year4.89%
Revenue Next 2Y6.18%
Revenue Next 3Y6.54%
Revenue Next 5Y6.95%
EBIT growth 1Y5.27%
EBIT growth 3Y3.54%
EBIT growth 5Y5.55%
EBIT Next Year27.49%
EBIT Next 3Y14.67%
EBIT Next 5Y11.91%
FCF growth 1Y268.5%
FCF growth 3Y9.61%
FCF growth 5Y6.39%
OCF growth 1Y140.59%
OCF growth 3Y9.24%
OCF growth 5Y6.9%

COLOPLAST-B / CBHD.DE FAQ

What is the ChartMill fundamental rating of COLOPLAST-B (CBHD.DE) stock?

ChartMill assigns a fundamental rating of 6 / 10 to CBHD.DE.


Can you provide the valuation status for COLOPLAST-B?

ChartMill assigns a valuation rating of 5 / 10 to COLOPLAST-B (CBHD.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for COLOPLAST-B?

COLOPLAST-B (CBHD.DE) has a profitability rating of 7 / 10.


How financially healthy is COLOPLAST-B?

The financial health rating of COLOPLAST-B (CBHD.DE) is 5 / 10.


What is the expected EPS growth for COLOPLAST-B (CBHD.DE) stock?

The Earnings per Share (EPS) of COLOPLAST-B (CBHD.DE) is expected to grow by 46.9% in the next year.